Live News EQUITY FLASH L impact Jul 30, 2026, 08:06 PM UTC

KPTI Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.